Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMS-001 in moderate to severe dementia
NCT06946511Phase 2Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PMS-001 in Dementia, sponsored by Ruijin Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
PMS-001
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT06946511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06946511.